Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-056681

Chief Business Officer sold 6,944 shares at $31.27 ($217,153)

  • Chief Business Officer acquired 6,944 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Parrish Jay · Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-02 Exercise or conversion : show line 1 in the form +4,629 $1.49 $6,874 226,851 D
2020-11-02 Exercise or conversion : show line 2 in the form +2,315 $1.58 $3,646 229,166 D
2020-11-02 Sale : show line 3 in the form −6,944 $31.27 $217,153 222,222 D
Open-market sales · 6,944 sh · avg $31.27 · $217,153

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-11-02 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −4,629 27,778 D
2020-11-02 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −2,315 48,611 D
Loading xslF345X03/doc4.xml…